Nasdaq

Jaguar Health Provides Updates on Canalevia (Crofelemer), the First Plant-based ...

SAN FRANCISCO, CA / ACCESSWIRE / May 18, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today provided updates regarding the development program for the Company's oral ...